Personalis (PSNL) reported preliminary Q4 revenue Thursday of $17 million to $18 million.

Analysts surveyed by FactSet expected $17.6 million.

For 2025, it reported preliminary revenue of $69 million to $70 million, down from $84.6 million a year earlier.

Analysts surveyed by FactSet expect $70 million.

The biotech firm ended 2025 with around $240 million in cash, cash equivalents, and short-term investments.

Shares of the company were down 2.7 in recent premarket activity.